Drugs / JTT-654
last change Apr 2010 re-read 3 minutes ago

JTT-654

Developed for
type 2 diabetes mellitus
Investigated by
Akros Pharma Inc.

Trials 1

201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00997152 Sep 2009 → Mar 2010 type 2 diabetes mellitus Akros Pharma Inc. Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as JTT-654 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00997152 ↗